cinacalcet
UkraineDrugs containing this active substance
-
The drug is used to treat secondary hyperparathyroidism in adults with end-stage renal disease undergoing hemodialysis. It is also used for parathyroid carcinoma, primary hyperparathyroidism, and to reduce blood calcium levels in appropriate adult patients.
Form: tablets, film-coated
Active substance Dosage cinacalcet 30 mg ATC: H05BX01
Manufacturer: Synthon, s.r.o. (batch release)
-
The drug is used to treat secondary hyperparathyroidism in adults with end-stage renal disease undergoing hemodialysis. It is also used for parathyroid carcinoma, primary hyperparathyroidism, and to reduce calcium levels in these conditions.
Form: tablets, film-coated
Active substance Dosage cinacalcet 60 mg ATC: H05BX01
Manufacturer: Synthon, s.r.o. (batch release)
-
The drug is used to treat secondary hyperparathyroidism in adults with end-stage renal disease undergoing hemodialysis. It is also used for parathyroid carcinoma, primary hyperparathyroidism, and to reduce blood calcium levels in appropriate adult patients.
Form: tablets, film-coated
Active substance Dosage cinacalcet 90 mg ATC: H05BX01
Manufacturer: Synthon, s.r.o. (batch release)
-
The drug is prescribed for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease undergoing dialysis. It is also used to lower calcium levels in cases of parathyroid carcinoma or primary hyperparathyroidism if surgery is impossible or contraindicated.
Form: tablets, film-coated
Active substance Dosage cinacalcet 30 mg ATC: H05BX01
Manufacturer: Hetero Labs Limited
-
The drug is used to treat secondary hyperparathyroidism in patients with end-stage renal disease undergoing dialysis. It is also prescribed to lower calcium levels in cases of parathyroid carcinoma or primary hyperparathyroidism if surgery is impossible or contraindicated.
Form: tablets, film-coated
Active substance Dosage cinacalcet 60 mg ATC: H05BX01
Manufacturer: Hetero Labs Limited
-
The drug is used to treat secondary hyperparathyroidism in patients with end-stage renal disease undergoing dialysis. It is also prescribed to lower calcium levels in cases of parathyroid carcinoma or primary hyperparathyroidism if surgery is impossible or contraindicated.
Form: tablets, film-coated
Active substance Dosage cinacalcet 90 mg ATC: H05BX01
Manufacturer: Hetero Labs Limited
-
The drug is used to treat secondary hyperparathyroidism in adult patients with end-stage renal disease undergoing hemodialysis. It is also used to reduce calcium levels in parathyroid carcinoma and primary hyperparathyroidism.
Form: tablets, film-coated
Active substance Dosage cinacalcet 30 mg ATC: H05BX01
Manufacturer: DEVA Holding A.S. (manufacturing of medicinal product, batch release; alternative unit for secondary packaging)
-
The drug is used to treat secondary hyperparathyroidism in adults on hemodialysis due to renal failure. Kokotsina is also prescribed to lower calcium levels in cases of parathyroid carcinoma or primary hyperparathyroidism.
Form: tablets, film-coated
Active substance Dosage cinacalcet 60 mg ATC: H05BX01
Manufacturer: DEVA Holding A.S. (manufacturing of medicinal product, batch release; alternative unit for secondary packaging)
-
The drug is used to treat secondary hyperparathyroidism in adult patients with end-stage renal disease undergoing hemodialysis. Kokotsina is also prescribed to reduce calcium levels in cases of parathyroid carcinoma or primary hyperparathyroidism if surgery is impossible or contraindicated.
Form: tablets, film-coated
Active substance Dosage cinacalcet 90 mg ATC: H05BX01
Manufacturer: DEVA Holding A.S. (manufacturing of medicinal product, batch release; alternative unit for secondary packaging)